Securities code: 002173 securities abbreviation: Innovation Medical Management Co.Ltd(002173) Announcement No.: 2022-002 Innovation Medical Management Co.Ltd(002173)
Pre disclosure announcement on reduction of shares held by shareholders holding more than 5%
Hangzhou Changjian investment partnership (limited partnership), Hangzhou lanchuang investment partnership (limited partnership) and Chen yuemeng guarantee that the information provided to the company is true, accurate and complete without false records, misleading statements or major omissions.
The company and all members of the board of directors guarantee that the contents of the announcement are consistent with the information provided by the information disclosure obligor.
Special tips:
Hangzhou Changjian investment partnership (limited partnership) (hereinafter referred to as “Changjian investment”), Hangzhou lanchuang investment partnership (limited partnership) (hereinafter referred to as “lanchuang investment”) and Chen yuemeng now hold 55178300 shares of Innovation Medical Management Co.Ltd(002173) (hereinafter referred to as “the company”) (accounting for 12.16% of the total share capital of the company). They plan to conduct block transactions The shares of the company shall be reduced by centralized bidding transaction or other legal means, and the reduction shall not exceed 32523840 shares, that is, not more than 7.17% of the total share capital of the company.
On December 31, 2021, the company received the notification letter on share reduction plan jointly submitted by Changjian investment, lanchuang investment and Chen yuemeng in the form of personal service. According to the guidelines for standardized operation of Listed Companies in Shenzhen Stock Exchange and some provisions on share reduction by shareholders, directors and supervisors of listed companies The detailed rules for the implementation of share reduction by shareholders, directors, supervisors and senior managers of Listed Companies in Shenzhen Stock Exchange and other relevant provisions are hereby announced as follows:
1、 Basic information of shareholders
1. Name of shareholders: Changjian investment, lanchuang investment, Chen yuemeng
2. The number of shares held by shareholders and the proportion of reduced shares in the total share capital of the company:
Name of shareholder number of shares held by the company the proportion of shares held by the company in the total planned reduction of shares of the company does not exceed (10000 shares) (%) the proportion of total share capital of the company (%)
Changjian investment 3395.597.48572.50
Lanchuang investment 1273.342.80712.81
Chen yuemeng 848.901.87141.86
Total 5517.8312.16427.17
2、 Main contents of this reduction plan
1. Reasons for reduction: in order to meet their own capital needs, shareholders continue to be optimistic about the development prospect of the company. 2. Source of shares: the shares obtained by the company through non-public offering after listing.
3. Proportion of the proposed reduction in the total share capital of the company:
The total reduction shall not exceed 32523840 shares (in case of share changes such as share bonus and conversion of capital reserve to share capital during the reduction plan period, the reduction shall be adjusted accordingly), that is, it shall not exceed 7.17% of the total share capital of the company.
4. Reduction method: block trading, centralized bidding trading or other legal methods.
5. Reduction time: if the shares are reduced through centralized bidding trading, the total number of shares reduced shall not exceed 1% of the total number of shares of the company within 6 months after 15 trading days from the date of disclosure of this announcement (i.e. January 25, 2022 to July 24, 2022) and any continuous 90 natural days; If the shares are reduced through block trading, the total number of shares reduced shall not exceed 2% of the total number of shares of the company within any continuous 90 natural days; If the shares are reduced by other legal means, it shall be determined according to the specific transaction method.
6. Reduction price: determined according to the market price and transaction mode at the time of reduction.
3、 Relevant risk tips
1. The above shareholders will determine the specific implementation of the share reduction plan according to the market conditions and their own conditions. There are uncertainties in the reduction time, quantity and price of the share reduction plan.
2. The share reduction plan complies with the securities law, several provisions on share reduction by shareholders, directors, supervisors and senior managers of listed companies, and the detailed rules for the implementation of share reduction by shareholders, directors, supervisors and senior managers of listed companies of Shenzhen Stock Exchange. The company will continue to pay attention to the follow-up implementation of the reduction plan, urge the above shareholders to reduce their holdings in strict accordance with the provisions of relevant laws and regulations, and timely perform the relevant information disclosure obligations.
3. The implementation of the share reduction plan will not lead to the change of the control right of the listed company, will not have an impact on the corporate governance structure, equity structure and sustainable operation, and there are no commitments that should be fulfilled but not fulfilled. Please invest rationally.
4、 The notice on share reduction plan jointly issued by Changjian investment, lanchuang investment and Chen yuemeng is hereby announced.
Innovation Medical Management Co.Ltd(002173) board of directors
January 4, 2022
